Patient Care

Syndax’s Revuforj® (revumenib) Included in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for the Treatment of Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia

NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies,...

Wellstar Health System Rolls Out the Swift™ AI Scheduling Copilot for Nursing Teams, the First Workforce Solution by vflok Inc.

ATLANTA, Sept. 18, 2025 /PRNewswire/ -- Workforce AI startup vflok™ Inc. is improving schedule flexibility and eliminating unnecessary workflows for...

error: Content is protected !!